Nicorandil Viatris (Nicorandil)

Nicorandil combines two mechanisms: it releases nitric oxide, which relaxes vascular smooth muscle, and it opens ATP‑sensitive potassium channels, causing arterial and venous dilation. This dual action reduces cardiac preload and afterload, lowering myocardial oxygen demand and alleviating angina.

The specific dose of Nicorandil Viatris is determined by the prescribing healthcare professional based on the patient’s clinical condition, response, and tolerance. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for Nicorandil in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nicorandil is unique because it combines nitrate‑like nitric‑oxide donation with potassium‑channel activation, offering both arterial and venous dilation. Compared with pure nitrates or beta‑blockers, it may provide additional symptom relief without the same degree of tolerance development, but individual response varies.

Nicorandil Viatris should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments to maintain stability.

Nicorandil Viatris is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration schedule, such as once or twice daily, is individualized based on the patient’s condition and therapeutic response.

Serious risks include severe hypotension, which can cause fainting, and rare but serious skin reactions such as Stevens‑Johnson syndrome. In rare cases, worsening angina or myocardial infarction may occur. Patients should seek immediate medical attention if they experience sudden severe chest pain, fainting, or extensive rash.

Nicorandil is contraindicated in patients with severe hypotension, cardiogenic shock, or recent myocardial infarction. Individuals taking other nitrates, PDE‑5 inhibitors, or potent vasodilators should avoid it unless closely supervised. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.